TCI Wealth Advisors Inc. Lowers Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

TCI Wealth Advisors Inc. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,719 shares of the healthcare conglomerate’s stock after selling 37 shares during the quarter. TCI Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $905,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. Richelieu Gestion SA acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $26,000. CGC Financial Services LLC increased its stake in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC boosted its holdings in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares during the last quarter. LFA Lugano Financial Advisors SA increased its position in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. Finally, Annapolis Financial Services LLC lifted its position in UnitedHealth Group by 38.6% during the 3rd quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock worth $40,000 after acquiring an additional 22 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Down 0.1 %

Shares of UNH traded down $0.52 on Friday, hitting $492.45. The company’s stock had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The firm’s fifty day moving average price is $482.32 and its 200-day moving average price is $512.42. The firm has a market capitalization of $453.09 billion, a price-to-earnings ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period last year, the business earned $6.26 EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.53%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on UNH. Piper Sandler raised their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Morgan Stanley cut their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Truist Financial restated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research report on Thursday, April 4th. Finally, Barclays lifted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.